Therefore, the dynamic monitoring of both HBP and CRP not only significantly improves the accuracy of prognostic assessments for sepsis patients but also provides clinicians with a more comprehensive tool for patient risk evaluation, potentially aiding in clinical decision-making. This evidence concerns the gene CRP and Sepsis.